...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith share issue
5
Nov 13, 2017 11:10PM
2
Nov 14, 2017 12:34PM
7
Nov 14, 2017 12:47PM
6
Nov 14, 2017 01:11PM

Please share details as to why you feel this way.  Any idea of what a buyout of this sort would render as a pps?

 

Thanks!

6
Nov 15, 2017 12:39PM
6
Nov 15, 2017 02:41PM
6
Nov 15, 2017 03:30PM
Share
New Message
Please login to post a reply